Patents for C07K 19 - Hybrid peptides (29,428) |
---|
01/04/2008 | CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
01/03/2008 | CA2656440A1 Improved sgp130fc dimers |
01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
01/02/2008 | EP1873166A1 Improved sgp 130Fc dimers |
01/02/2008 | EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
01/02/2008 | EP1871880A2 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
01/02/2008 | EP1871785A2 Compositions and methods for fusion protein separation |
01/02/2008 | EP1871412A2 Soluble vox2 protein as immunoregulatory factor |
01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
01/02/2008 | EP1303606B1 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
01/02/2008 | EP0863987B1 Vectors and methods for gene transfer to cells |
01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
01/02/2008 | CN101098891A Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
01/02/2008 | CN101096660A Fusion protein PEG-rSAK novel thrombolytic drug and its preparation method |
01/02/2008 | CN101096386A Dectin-1 and heat shock protein Hsp60 polymer and coding nucleic acid and application thereof |
01/02/2008 | CN101096385A Preparation method of fused protein for antioxidation and preventing diabetes and application thereof |
01/02/2008 | CN101096384A Preparation method of fused protein for antitumor and application thereof |
01/02/2008 | CN101096383A Fusion protein of pellicle growing gene and green fluorescence albumen |
01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
01/01/2008 | US7314915 Fluorescent proteins |
01/01/2008 | US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations |
01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
01/01/2008 | US7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli |
01/01/2008 | US7314747 SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors |
01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
12/27/2007 | WO2007150020A1 Targeted immune conjugates |
12/27/2007 | WO2007148317A1 Mcp-1 splice variants and methods of using same |
12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
12/27/2007 | DE19964386B4 Screening drugs disrupting macrophage migration inhibitory factor-cJun activation domain binding protein1 interaction involves comparing MIF-Jab1 interaction, in presence and absence of drug in MIF and Jab1 system |
12/27/2007 | CA2690973A1 Targeted immune conjugates |
12/26/2007 | EP1401869B1 Molecules and methods for inhibiting shedding of kim-1 |
12/26/2007 | EP0877812B1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
12/26/2007 | EP0517829B2 Improved chimeric toxins |
12/26/2007 | CN101094863A Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
12/26/2007 | CN101092616A Expressing and purifying neutrophilic granule protein NGP |
12/26/2007 | CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents |
12/26/2007 | CN101092452A Preparation method for both of micromolecule polypeptide of tumor chalone for anti angiogenesis, and fusion protein |
12/26/2007 | CN100357442C Efficient fusion expression carrier |
12/26/2007 | CN100357314C Method for linking molecular substances |
12/25/2007 | US7312080 Plant resistance to insect pests mediated by viral proteins |
12/25/2007 | US7311922 comprising antigens and excipients, which increse serological sensitivity of individuals infected with tuberculosis; for use in diagnosis and prevention of tuberculosis infection |
12/25/2007 | US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response |
12/25/2007 | US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy |
12/21/2007 | WO2007144990A1 Mutant luciferase |
12/21/2007 | WO2007144730A1 Compositions and methods for delivering anti-activated ras antibodies into cells |
12/21/2007 | WO2007144173A1 Proteolytically cleavable fusion protein comprising a blood coagulation factor |
12/21/2007 | WO2007143917A1 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody |
12/21/2007 | WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them |
12/21/2007 | CA2655248A1 Proteolytically cleavable fusion protein comprising a blood coagulation factor |
12/21/2007 | CA2654701A1 Cholesterol-regulating complex of sirt1 and lxr and methods of use |
12/20/2007 | US20070292944 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors |
12/20/2007 | DE102006028076A1 APlase-Proteinkonstrukt APlase protein construct |
12/20/2007 | CA2635467A1 Bst2 inhibitor |
12/19/2007 | EP1867661A1 Compositions and methods for delivering anti-activated ras antibodies into cells |
12/19/2007 | EP1867660A1 Proteolytically cleavable fusion protein comprising a blood coagulation factor |
12/19/2007 | EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
12/19/2007 | EP1866340A1 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
12/19/2007 | EP1311540B1 Altered ospa of borrelia burgdorferi |
12/19/2007 | EP1179593B1 Process for producing recombinant insulin from novel fused protein |
12/19/2007 | CN101089180A Recombination LFA3 gene, and its mixed gene and product |
12/19/2007 | CN100355950C Polypeptide random library and its construction method, and method for screening polypeptide capable of penetrating cell from the library |
12/19/2007 | CN100355893C Method of expressing heparinase and its special expression carrier |
12/19/2007 | CN100355788C Activated collagen protein stent material and its special restoration factor for binding |
12/19/2007 | CN100355787C Activated collagen bone restoration material and its special bone restoration factor for bone binding |
12/18/2007 | US7309768 PRO4347 polypeptides |
12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
12/18/2007 | US7309586 Chimeric coiled coil molecules |
12/18/2007 | CA2179562C Peptide useful in the separation and purification of immunoglobulins |
12/18/2007 | CA2062047C Fusion proteins for prodrug activation, the preparation and use thereof |
12/13/2007 | WO2007142300A1 Method of producing lymphocytes |
12/13/2007 | WO2007142208A1 Temperature-responsive protein and polynucleotide, plasmid and cell expressing the temperature-responsive protein and method of using the temperature-responsive protein |
12/13/2007 | WO2007140667A1 A ptd-vp3 fusion protein as anti-tumor medecine and preparing process |
12/13/2007 | WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
12/13/2007 | WO2007140545A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore |
12/13/2007 | WO2007140505A2 Vaccine carrier |
12/13/2007 | WO2007072461A3 Modified proteins comprising a bioactive peptide/protein linked to a sequence of aminoacids containing a human carbohydrate binding module (cbm), and development of a system for the administration of therapeutically active proteins and respective utilizations for biomedical purposes |
12/13/2007 | US20070287660 Chimeric metalloenzyme comprising fibrin binding domain for for use in treatment and prevention of thrombosis and cardiovascular disorders |
12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
12/13/2007 | CA2657971A1 Vaccine carrier |
12/13/2007 | CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
12/12/2007 | EP1865062A2 Altered OspA of Borrelia burgdorferi |
12/12/2007 | EP1865061A2 IL-17 homologous polypeptides and therapeutic uses thereof |
12/12/2007 | EP1865000A1 Monoclonal antibody specific to denatured human leukocyte antigen class i |
12/12/2007 | EP1864681A1 Growth factor modified protein matrices for tissue engineering |
12/12/2007 | EP1863910A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
12/12/2007 | EP1863850A1 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
12/12/2007 | EP1863830A2 Affinity purification of protein |
12/12/2007 | EP1237912B1 Five-helix protein |
12/12/2007 | EP1144454B1 Modified peptides as therapeutic agents |
12/12/2007 | EP0723555B1 Chimeric proteins which block complement activation |
12/12/2007 | CN101087809A Hybrid enzymes |
12/12/2007 | CN101087808A Compositions of influenza viral proteins and methods of use thereof |
12/12/2007 | CN101085813A Soluble TNF acceptor mutant |
12/12/2007 | CN100354307C NOGO receptor-mediated blockade of axonal growth |
12/12/2007 | CN100353846C Novel insecticidal toxins derived from bacillus thuringiensis insecticidal crystal proteins |
12/11/2007 | US7307148 Method for purification of albumin conjugates |